Integrated Advisors Network’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
ACM
KGAMU
JCM
Integrated Advisors Network's CDLX Position: Q3 2022 in Review
Integrated Advisors Network sold out of Cardlytics (CDLX) in Q3 2022, closing a stake of 4,274 shares — an estimated $954K sold.
Integrated Advisors Network first reported a position in CDLX in Q3 2021 and held it in 3 quarters. The position peaked at $3.05M in Q1 2022. 132 funds tracked by Wall St. Rank hold CDLX as of Q3 2022.
- Integrated Advisors Network reported no remaining Cardlytics position as of Q3 2022 after selling out during the quarter.
- Integrated Advisors Network sold 4,274 Cardlytics shares in Q3 2022, an estimated $954K.
- Integrated Advisors Network first reported a position in Cardlytics in Q3 2021 and held it in 3 quarters.
- Integrated Advisors Network's Cardlytics position peaked at $3.05M in Q1 2022.
- 132 funds tracked by Wall St. Rank held Cardlytics as of Q3 2022.
Based on Integrated Advisors Network's 13F filing for Q3 2022, filed 8 Nov 2022.